A diet derived agent Curcumin (Diferuloylmethane), demonstrated its clinical application in inflammation, infection and cancer conditions. Nevertheless, its impact on the proteome of epithelial cells of non-small cell lung carcinoma (NSCLC) still needs further attention. We employed a stable isotope labeling method for cell culture (SILAC) based relative quantitative proteomics and informatics analysis to comprehend global proteome change in A549 cells treated to curcumin and/or Lipopolysaccharide (LPS). Pretreated A549 cells were infected with Mycobacterium tuberculosis H37Rv strain to monitor bacterial entry and load. With exposure to curcumin and LPS, out of the 1492 identified proteins, 305 and 346 proteins showed deregulation respectively. The expression of BID and AIFM1 mitochondrial proteins which play critical role in apoptotic pathway was deregulated in curcumin treated cells. A549 cells treated with curcumin showed higher active mitochondria intensity with respect to LPS treatment. Simultaneous treatment of curcumin and LPS neutralized the effect of LPS.
the hour. Curcumin has been reported to arrest cell-cycle followed by apoptosis in A549 cells (14) .
In this study, we aim to explore the role of curcumin on LPS exposed A549 cells. LPS elicit a strong immune response in animals through Toll-like receptors (TLRs) mainly TLR4, that triggers the pro-inflammatory response to eradicate the bacteria (15) . Establishing the mechanism of curcumin action on LPS treated A549 cells by characterizing cellular proteome and on Mycobacterium tuberculosis infection might be useful to identify novel targets to reduce LPS induced damage in different disease conditions. Figure 2A , treatment with curcumin (10 M) or LPS (1 g/ml) for 24 h did not show any significant reduction in cell viability. Cells treated with both LPS and Curcumin showed a 23.3% reduction as compared to control. DNA contents of A549 cells in CURI, LPSI and LPSCUR showed curcumin or LPS inhibits cell cycle arrest ( Figure 2B , Figure S1 in the Supporting Information).
Results:

Effect of curcumin/LPS or both on A549 cell viability and apoptosis: As shown in
The Annexin V-positive cells were significantly increased as a result of cells undergoing earlyapoptotic and late-apoptotic phase and the rates were 85.1%, 86.1% and 72.1% in CURI, LPSI and LPSCUR respectively ( Figure 2C ). The apoptotic cells in simultaneous curcumin and LPS treatment were lowest with respect to individual treatment with curcumin or LPS.
Proteome Profiles of A549 cells treated with Curcumin and LPS:
To characterize the temporal proteome alteration in A549 cells with response to curcumin and/or LPS treatment, a comparative quantitative proteomics approach was adopted in this study. We cultured the cells in heavy isotope media for over 10 doubling and confirmed the incorporation of heavy isotope to be over 99% by running the samples on mass spectrometer. In the CURI, LPSI and LPSCUR experiments, a total of 1109, 1135 and 1155 proteins respectively were identified at 1% FDR at both protein and peptide levels ( Figure 3A) . Altogether we identified a total 1492 distinct proteins at least once in these 3 experiments (Table S1 in the Supporting Information). A set of 81, 204 and 78 unique proteins were identified in CURI, LPSI and LPSCUR respectively and 778 proteins were common in all these experiments. Functional interaction network of common proteins resulted in 696 original nodes with 73 linker genes. These genes were clustered in 7 modules with a modularity of 0.53 and explained to participate in different GO biological processes viz. translation, protein folding, respiratory electron transport chain, RNA splicing and TCA cycle ( Figure 3B ). A total of 804, 789 and 783 proteins showed similar abundance in CURI, LPSI and LPSCUR respectively ( Figure 3C ). Common 427 proteins mostly represent house-keeping genes, forms a network with 8 modules (385 nodes with 47 linker genes) and 0.53 modularity. Major GO biological processes explained by these common proteins were translation, protein folding and apoptosis process ( Figure 3D ). Venn diagram representing the total number of deregulated proteins (log2 fold change ≥ ± 1) in CURI, LPSI and LPSCUR presented in Figure S2 in the Supporting Information.
Treatment of A549 cells with curcumin or LPS for 24 hours:
In CURI, out of 1109, 3 proteins were up-regulated; while 302 were down-regulated. In LPSI, 333 proteins were up-regulated and 13 proteins were found to be down-regulated ( Figure 4A ). Out of the 305 deregulated proteins in CURI, 257 nodes were mapped with 75 linker genes resulting 13 modules ( Figure   S3A in the Supporting Information). Out of the 346 deregulated proteins from LPSI, 265 nodes with 65 linkers formed a network resulting 12 modules ( Figure S3B in the Supporting Information). Modularity of CURI and LPSI were calculated to be 0.45, 0.65 respectively.
These molecules involved in diverse molecular functions viz. translation regulator activity, binding, receptor activity, structural molecule activity, catalytic activity, antioxidant activity and transporter activity. Molecular functions like binding and catalytic activity were found to be up higher in LPSI and reversely regulated in CURI ( Figure 4B ). Interestingly a set of mitochondrial proteins (n=17) showed significant inverse relationship between protein abundance in LPS and CUR treated cells ( Figure 4C ). BID protein showed significant down regulation on curcumin treatment. AIFM1 showed similar abundance on curcumin treatment but up-regulated on simultaneous treatment and could be an important target of curcumin in apoptotic pathway.
Functional network analysis of 90 common deregulated proteins between CURI and LPSI experiments resulted a network with 35 nodes. The genes involved in translation process accounts for ~31.4 %, RNA splicing ~20 % and other linked genes ~48.6 % ( Figure S3C in the Supporting Information).
Simultaneous treatment of A549 cells with curcumin and LPS for 48 hours:
In LPSCUR experiment, 366 proteins were up-regulated and 6 were down-regulated ( Figure 4D ). From the 372 deregulated proteins, 317 nodes with 76 linker genes generated 9 modules with 0.54 modularity ( Figure S4 in the Supporting Information). Majority of these proteins explained GO biological processes like translation, protein folding, protein targeting to mitochondrion, RNA splicing and respiratory electron transport chain ( Figure 4E ). Majority of the up-regulated proteins in LPSCUR involves in binding and catalytic activities ( Figure 4E ).
In fact, 878 proteins were found to be common between LPSI and LPSCUR. Majority of these proteins (~60 %) showed similar abundance in both the exposure and 15% proteins showed upregulation in both these experiments. A set of proteins (14.46 %) were up-regulated in LPSCUR and did not show any variation in LPS treated cells. Similarly, a set of proteins (8.77%) were up-regulated in LPSI and did not show any change in both LPS and curcumin treated cells ( Figure S5 in the Supporting Information). These variations indicate a time dependent change in LPSI and LPSCUR experiments as the incubation periods were different for LPSI (24 hours) and LPSCUR 48 hours).
Phosphoproteome analysis of A549 cells treated with curcumin and LPS:
Majority of the phosphosites was found to be contributed from Serine residues in CURI and LPSI experiment, but none in LPSCUR experiments. Most of the phosphoproteins in CURI, LPSI and LPSCUR were singly or doubly phosphorylated ( Figure S6A -C in the Supporting Information).
Monitoring important proteins in an independent sample set using Western Blot and mRNA
using qRT-PCR: These important pro-apototic marker protein BID and apoptosis inducing factor protein AIFM1 were probed using Western blot experiments. AIFM1 protein showed similar changes in western blot experiment and supported Mass Spectrometry data ( Figure 6A and Figure S7 in the Supporting Information). In Western blot experiments, BID protein showed down regulation similar to the mass spectrometry data ( Figure 6A and Figure S7 in the Supporting Information). In LPSCUR experiments, western blot data did not match mass spectrometry fold change values ( Figure 6A and Figure S7 in the Supporting Information). At the transcript levels of BID and AIfM1, we did not find any significant variation in their expression in all these experiments ( Figure 6B ). Additional blots and corresponding silver stained gels are presented in Figure S7A -B.
Mitochondrial integrity and health: From the confocal/N-SIM microscopy experiments, we
observed the mean intensity of mitochondria in CURI was significantly higher to control and remain unchanged in LPS exposed cells ( Figure 6C , 6D). Low mean mitochondrial intensity was observed in LPSCUR with respect to 48 hours' control with statistically insignificant change.
A549 cells pre-treated to Curcumin and/or LPS exposure upon infection showed varied
Mycobacterial load: Pretreated A549 cells, with CURI, LPS or LPSCUR, when infected with laboratory strains of virulent Mycobacteria strain (H37Rv) showed successful internalization and varied bacterial load ( Figure 7A , 7B, Figure S8A -C in the Supporting Information). We observed higher bacterial load in cells preincubated with LPS, however curcumin preexposed cells (CURI) showed similar bacterial load with respect to controls. Whereas at 48 hours post infection cells exposed to both LPS and curcumin (LPSCUR) showed lower but statistically insignificant difference in bacterial load with respect to controls. This suggests an antiinflammatory role of curcumin to the effect of LPS on Mycobacterium tuberculosis infection.
Discussion:
Curcumin has been used as a dietary supplement and by recent evidence demonstrated its chemopreventive and chemo protectant role as suggested on its tumour suppressive and apoptosis inducing activities (16) . Here we report that curcumin has anti-inflammatory role at proteome level which reduces the damage caused by LPS on A549 cells.
Curcumin and/or LPS treatment, at the concentration and time duration used in this study, did not affect growth of the A549 cells. One of the major checkpoints in cell cycle is G2/M and defective checkpoint function leads to tumorigenesis. Therefore, the regulation of checkpoint signalling is important and it can alter tumor cells sensitivity to drugs (17) . However, the major strategy of eliminating tumor cells is by arresting the cell-cycle (18) . Curcumin and LPS treatment results in cell cycle arrest in A549 cells at G2/M phase. Our data corroborated the earlier finding of curcumin on human melanoma cells (19) . But upon simultaneous treatment, there is a decrease in the G2/M phase cells and increase in S phase cells suggesting chemo protective role of curcumin in presence of LPS.
Our global proteomics experiment on A549 cells with and without curcumin and/or LPS treatment provides important data sets which were missing in the literature. Effect of curcumin in the global proteome change provided important insight and network analysis showed that majority of the commonly identified proteins (n=778) involved in diverse molecular functions such as RNA splicing, translation and protein folding, TCA cycle and respiratory electron transport chain. A total of 427 proteins were common in all these experiments, with similar in abundance irrespective of the perturbations, contributes in translation, protein folding and apoptotic process.
Curcumin induces apoptosis through mitochondrial pathways which are reported to be activated during pharmacological deregulation of proteins and proteasome function. This results into the deregulation of several proteins involved in the biogenesis, transport and activity of mitochondria on curcumin treatment. Interestingly, 17 mitochondrial proteins (STOML2, PDHA1, PITRM1, PTRH2, FDXR, PMPCB, TOMM22, TIMM50, FH, GFM1, APEX1, COX5B, CYB5B, ATP5H, HSD17B10, MRPL28 and MRPL13) inversely expressed on curcumin or LPS treatment which suggests that curcumin inhibits majority of proteins involved in apoptotic pathway. How curcumin disturbs the cellular functions is not yet clear.
But it could do so by binding and/or regulating some of the important proteins required for the gene expression or by inducing oxidative stress (20, 21) . These results demonstrated the antioxidant activity of curcumin (22) . Bacterial LPS or endotoxins are responsible for the activation of the innate immune response and antigen-specific immune response by binding to various cell surface receptors (23) . We analyzed the anti-inflammatory effect and mechanism of action of curcumin in regulating the TLR-4 signaling pathway in A549 cells. It has been reported that curcumin is involved in the inhibition of many important processes such as homodimerization of TLR-4 (24) . We identified an Interferon-induced, double-stranded RNAactivated protein kinase (PKR) in both CURI and LPSI experiments having similar expression level. PKR plays a key role in the innate immune response to viral infection and is also involved in the regulation of signal transduction, apoptosis, cell proliferation and differentiation.
Apoptosis is the cellular mechanism of undergoing programmed cell death by the means of many apoptotic proteins ( Figure 4 ). Apoptosis occurs via a mitochondrial-dependent intrinsic pathway or a death receptor-mediated extrinsic pathway (25, 26, 27) . Curcumin causes dosedependent apoptosis and DNA fragmentation of Caki cells, which is preceded by the sequential dephosphorylation of Akt, down-regulation of the anti-apoptotic Bcl-2, Bcl-XL and IAP proteins, release of cytochrome c and activation of caspase 3 (16) .
Curcumin treatment down regulated BH3-interacting domain death agonist (BID) suggesting that this pro-apoptotic protein deactivate the antiapoptotic function of Bcl-2/Bcl-xL allows the formation of pores on the outer mitochondrial membrane and cytochrome c release from mitochondria (28) . In our present study we identified two proteins from the apoptotic pathway. BID, which is a member of the Bcl-2 family of proteins that regulate the permeabilization of the outer mitochondrial membrane (OMM), a critical event during apoptosis show significant down regulation (log2 fold change = -1.31) with curcumin exposure.
The other Apoptosis-inducing factor 1(AIFM1-1) shows up regulation upon simultaneous treatment with LPS and curcumin (log2 fold change = 1.32), functions as regulator of apoptosis in a caspase-independent pathway. Diablo homolog identified in curcumin treated cells is reported to release to the cytosol from mitochondrial intermembrane space. It promotes apoptosis by activating caspases in the cytochrome c/Apaf-1/caspase-9 pathway and acts by affecting the inhibitory activity of IAP (inhibitor of apoptosis proteins) (29) . Bax was identified in all three experiments with similar abundance. Indeed, curcumin was reported to promote Bax oligomerization, via a caspase-independent mechanism, suggesting that Bax activation and oligomerization are early events during curcumin-induced caspase activation.
Apoptosis-inducing factor is a mitochondrial flavoprotein, which normally resides in the inner mitochondrial membrane, and it possesses an NADH oxidase activity (30) . We observed upregulation of AIF level in LPS treated A549 cells that acts as a scavenger of ROS, particularly peroxides (31) . Translocation of AIF from the mitochondria to the cytosol as well as to the nucleus exerts caspase-independent apoptosis in a number of model systems (32, 33) .
AIF can trigger nuclear apoptosis in a caspase-independent manner (34) . Curcumin induces AIF translocation from mitochondria to the cytosol and the nucleus (35) .
We observed high mitochondrial intensity in A549 cells treated with curcumin. Earlier reports on SHSY5Y cells treated with curcumin (66.3 µM) for 24 hours demonstrated enhanced mitochondrial function (36) . These modifications in mitochondrial function could be due to increased mitochondrial ATP, cytochrome oxidase activity, and reduced free radicals and oxidative stress (40) . Curcumin treated MCF-7 breast cancer cells showed suppressed cellular oxygen consumption rate, cell mitochondrial membrane potential and ROS generation, and shifting of metabolism from mitochondrial respiration to glycolytic flux (37) . These findings strongly suggest that curcumin boosts mitochondrial function to promote cell longevity and its anticancer action. Mice (db/db) treated with curcumin demonstrated diminished mitochondrial dysfunction in mitochondria isolated from the liver and kidneys of these mice (38) . We observed successful internalization of H37Rv Mtb strains in all pre-treated A549 cells with either LPS and/or curcumin treatment by confocal microscopy. Curcumin pretreated A549 cells showed similar bacterial load as controls but LPS pretreated cells showed significantly higher Mtb load than control. Interestingly, in A549 cells treated with LPS and CUR for 48 hours, lower Mtb bacterial load with respect to the control groups was observed. It indicates that Curcumin may be countering the effect of LPS on the A549 cells. Pretreatment of primary cells or cell lines with LPS contributes a change in phenotype and affect the clearance of intracellular pathogens. Macrophages chronically exposed to LPS reported to show compromised TNFα production. In response to secondary LPS challenges and treatment with murayl dipeptide partially restores TNFα production, and antimicrobial activity in these cells (40) . Animal experiments might provide further useful information on the chemoprotective role of Curcumin. In H37Rv infected mice model, introduction of Curcumin nanoparticles by intraperitoneal route to mice at 100 mg/kg body weight with tuberculosis drugs, improved Mycobacteria clearance by promoting antitubercular immunity (41) . In fact, the team also demonstrated that animals receiving curcumin were attaining sterile immunity and protected from reactivation of TB. In a separate study, curcumin inhibited intracellular growth of clinical MDR and laboratory Mtb H37Rv strains in Raw 264.7 cell line (42) .
CONCLUSIONS
Our results provide a detailed proteomics insight into the pathways mediated by curcumin to counteract the effect of LPS in A549 cells. We observed several deregulated proteins in curcumin and/or LPS exposed cells involved in TLR4 and apoptotic signaling pathways. BID protein from the apoptotic signaling pathway was inhibited with curcumin treatment. AIFM1 protein, from the apoptotic signaling pathway, showed upregulation with curcumin and LPS treatment. Therefore, BID and AIFM1 proteins can be used as potential targets of curcumin.
Curcumin and LPS exposed cells show varied Mycobacterial load and when exposed to both, the bacterial load was similar to controls. These findings could relate to the mechanism of curcumin as a chemopreventive, antioxidative and anti-inflammatory agent. Thus, curcumin could be used as a potential therapeutic agent for the development of novel anti-inflammatory and anticancer drugs with limited side-effects. 
Treatment Method of Cultured Cells
A schematic detail of the experimental setups used in this study is presented in Figure 1 . In the first experimental set up (CURI), cells were grown in presence of heavy labeled amino acids with Curcumin (10 µM) and light labeled amino acids for 24 hours at 37 °C with 5% CO2. In the second experiment (LPSI), cells were grown in light labeled amino acids with LPS (1 µg/ml) and heavy labeled amino acids for 24 hours at 37 °C. In the third experiment (LPSCUR), cells were grown with light labeled amino acids with both LPS (1 µg/ml) and Curcumin (10 µM, Sigma-Aldrich, St. Louis, MO) and heavy labeled amino acids with LPS (1 µg/ml) cultured for extended period of 48 hours at 37 °C.
Cell viability was estimated using the CellTiter 96(R) AQueous One Solution Cell Proliferation Assay (Promega, Madison, USA). Briefly, 10 µL of reagent was added per 100 µL of medium in each well, the plates were incubated at 37 °C for 1 hour, and the absorbance was read at 490 nm using a microplate reader (SpectraMax, Molecular Devices Co., Sunnyvale, CA, USA). Flowing Software (vs. 2.5.1, University of Turku, Finland) was used for the data analysis.
Cell apoptosis measurement
Sample Preparation for Cell Proteome Analysis
After the mentioned incubation periods, cells were harvested by centrifugation (15, The resolution of the instrument was set to 60,000 with a target value of 1E6 charges in the LTQ mass analyzer. The six most-intense precursor ions were selected from the data dependent MS scan for subsequent collision-induced dissociation (CID). Fragmentation in the LTQ was performed with a target value of 5,000 ions, normalized collision energy of 35% and ion selection threshold of 1,000 counts. Charge state screening was enabled for +2, +3, +4, and above ions. The parameters that were used for dynamic exclusion were as follows: repeat count-1, repeat duration-20, list size-500, exclusion duration-40. A total of 8 LC-MS/MS data files for CURI, 10 each for LPSI and LPSCUR were generated.
NanoLC-MS/MS Analysis
Data Analysis for Cell Proteome and Phosphoproteome using MaxQuant and Perseus
All raw MS files from each experiment were processed for peak detection and quantification by using MaxQuant (1.5.2.8). Peptide identification was performed by using the Andromeda search engine and Swiss-Prot database (89,796 human protein entries as on 10 th January 2015).
The experimental design included all three experiments (CURI, LPSI and LPSCUR) following the steps as described earlier. Search criteria used in this study were trypsin specificity, fixed modification of carbamidomethyl (cysteine), variable modifications of oxidation (methionine), and allowed for up to two missed cleavages. A minimum of six amino acids in the peptide length were required for identification. By using a decoy database strategy, peptide identification was accepted based on the posterior error probability with a false discovery rate (FDR) of 1%. The precursor mass tolerance was set at 6 ppm and the fragments ion tolerance Table   S1 in the Supporting Information). The results obtained from MaxQuant were further evaluated by Perseus and plots were generated using OrginPro 8.0 software.
Phosphopeptides were identified using an additional variable modification of phosphorylation (Serine, Threonine and Tyrosine: STY). The precursor mass tolerance was set at 4.5 ppm and the fragments ion tolerance was 20 ppm. The minimum peptide length was set to 7 with matching time window of 0.7 min. For identification of phosphorylation sites, the maximum FDR was set to 0.01. Phsophorylation sites were considered as "class I" if the localization probability was at least 0.75 (75%) and the localization score difference is greater than 5 (43, 44) . The number of phosphosites, distribution of charge states and number of phosphogroups per peptide in each CURI, LPSI and LPSCUR experiments were calculated using the phospho (STY) sites file obtained as output from MaxQuant ( Table S2 in the Supporting Information).
Data Availability
All the MS/MS proteomics data files (.raw and .mgf), phosphoproteome data and output tables of MaxQuant analysis have been deposited in the ProteomeXchange Consortium (PXD012652) (45) .
Analysis of protein-protein interactions and functional characterization
The deregulated protein lists from CURI, LPSI and LPSCUR were converted to gene list by employing Uniprot "Retrieve ID mapping" option. The gene list was used as input to Reactome Functional Interaction (ver. 4.2.0 beta) application in Cytoscape (ver. 3.4.0) to construct network with 2015 algorithm for "gene sets" using "Fetch FI annotations" and "use linker genes". Genes were clustered by the spectral partitioning-based network clustering algorithm using the clustering FI network option (46) . The FDR for the analysis of GO Biological processes was set to 0.05. Further network functions were analyzed for "Gene Ontology Biological Processes" of all clusters. To get molecular function information, Protein ANalysis THrough Evolutionary Relationships (PANTHER) database (ver. 11.0) was used and the deregulated genes in CURI, LPSI and LPSCUR experiments were used as input parameters.
Monitoring Important proteins using Western blot Experiments
Important mitochondrial proteins (log2 fold change ≥ ±1) identified in any of these experiments, were monitored in a separate set of experimental protein samples extracted from control and treated cells. Isolated proteins were separated on 12% SDS-PAGE and transferred to a PVDF membrane (FluoroTrans, Pall Life Sciences). After blocking with BSA (3 %) in TBST, blots were incubated with primary antibodies BID (1:1000, sc-373939, Santa Cruz, CA, USA), AIFM1 (1:1000, sc-55519, Santa Cruz, CA, USA) and β-actin (1:1000, sc-47778, Santa Cruz, CA, USA) overnight at 4 o C. Blots were then washed and incubated with goat anti-mouse secondary antibody labeled with HRP (sc-2060, Santa Cruz, CA, USA) and protein bands were visualized using the SuperSignal West Pico PLUS Substrate kit (Thermo Fisher Scientific, Waltham, MA). Relative band intensities were calculated using ImageJ software (Bethesda, MD, USA) with respect to -actin which was used as loading control.
qRT-PCR
To monitor expression of BID and AIFM1 gene at transcript level, qRT-PCR was performed from a separate set of treated samples. β-actin mRNA was used as an endogenous control. Total (reverse) and for AIFM1 were 5'-TAGGGCTGACACCAGAACAG-3' (forward) and 5'-GTGCCTCCACCAATTAGCAG-3' (reverse). qPCR reactions were performed for each cDNA sample in triplicate for each gene with non template control in duplicates and repeated at least three times. Cycling parameters used for qPCR was as follows: UDG activation for 2 min at 50 °C, Dual-Lock DNA polymerase step for 2 min at 90 °C, and an initial denaturation step of 3 sec at 95 °C with 40 cycles and annealing/extension of 30 sec at 62 °C. The relative quantity of mRNAs was determined using the CFX Manager software.
Monitoring Mitochondrial distribution in treated A549 cells using Confocal Microscopy
A549 cells were grown overnight on 18 mm coverslip in twelve well plates at 37 °C with 5% CO2 and incubated with curcumin/LPS/both for appropriate durations. Cells were washed 3 times with PBS and treated with fresh DMEM/F12 medium supplemented with MitoTracker® 
Infection experiments:
A549 cells cultured in DMEM/F-12 supplemented with 10% FBS media, were pretreated with curcumin, LPS or both, for the stipulated period before incubating with GFP-labeled CFU count was performed after 15 days of incubation and expressed in log10CFU/ml.
Statistical Analysis
Relative intensities of western blot band and mean intensity of fluorescence of mitochondria 
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